Andover, MA, United States of America

Yao-Ling Qiu

USPTO Granted Patents = 74 

 

 

Average Co-Inventor Count = 5.9

ph-index = 12

Forward Citations = 442(Granted Patents)

Forward Citations (Not Self Cited) = 305(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Somerville, MA (US) (2003 - 2004)
  • Andover, MA (US) (2004 - 2024)

Company Filing History:


Years Active: 2003-2024

Loading Chart...
Loading Chart...
Loading Chart...
74 patents (USPTO):

Title: Yao-Ling Qiu: Innovator in Antiviral Agents

Introduction

Yao-Ling Qiu, an accomplished inventor based in Andover, MA, has made significant contributions to the field of antiviral agents, particularly in the treatment of Hepatitis B virus (HBV). With a remarkable portfolio of 74 patents, Qiu stands out as a leading figure in pharmaceutical innovation.

Latest Patents

Among his latest inventions, Qiu has developed novel Hepatitis B antiviral agents. These compounds, represented by Formula (I), are designed to inhibit the proteins encoded by the hepatitis B virus, thereby interfering with the viral life cycle. These compounds not only function as antiviral agents but also form the basis for pharmaceutical compositions aimed at treating subjects suffering from HBV infection. The inventive methodologies proposed include administering these compositions to effectively combat the HBV infection.

Career Highlights

Qiu has an extensive career in the pharmaceutical industry, having worked with notable companies, including Enanta Pharmaceuticals, Inc. and Novartis AG. His innovative spirit and dedication to research are evident in his extensive patent portfolio, which reflects his commitment to advancing antiviral therapies.

Collaborations

Throughout his career, Qiu has collaborated with other esteemed professionals. Among his notable coworkers are Yat Sun Or and Xiaowen Peng, both of whom contribute their expertise to the field and complement Qiu's research efforts.

Conclusion

Yao-Ling Qiu's work in developing antiviral agents for Hepatitis B showcases his dedication to medical innovation. With numerous patents to his name and impactful collaborations, Qiu continues to push the boundaries of pharmaceutical research and development. His contributions are helping to pave the way for new treatments that could significantly improve the lives of those affected by HBV.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…